CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
300888 Winner Medical
- 52.22
- +0.14+0.27%
Market Closed Apr 30 15:00 CST
30.41BMarket Cap39.92P/E (TTM)
54.80High51.32Low75.00KlotVolume52.08Open52.08Pre Close400.20MTurnover4.27%Turnover Ratio43.74P/E (Static)582.33MShares54.8052wk High2.66P/B9.16BFloat Cap22.9152wk Low62.50Limit Up175.51MShs Float151.96Historical High41.66Limit Down6.68%Amplitude22.91Historical Low0.90Dividend TTM53.36Avg Price36.47KlotAsk1.72%Div YieldTTM100Lot Size32.57KlotBid
Winner Medical Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 42.72%2.6B | 13.23%10.02B | 3.42%6.12B | -3.83%3.99B | -14.29%1.82B | -28.16%8.85B | -25.38%5.91B | -18.91%4.15B | -13.90%2.13B | 43.83%12.31B |
| Refunds of taxes and levies | 49.83%37.99M | 44.22%114.91M | 48.39%91.63M | 67.63%65.62M | 130.29%25.35M | 511.22%79.67M | -19.73%61.75M | -28.15%39.15M | 25.47%11.01M | -79.22%13.03M |
| Cash received relating to other operating activities | 41.98%51.73M | 11.89%198.11M | -20.23%160.24M | -63.28%55.89M | -36.31%36.44M | -17.99%177.06M | 73.95%200.88M | 171.28%152.21M | 251.13%57.21M | 15.63%215.91M |
| Cash inflows from operating activities | 42.80%2.69B | 13.48%10.33B | 3.10%6.37B | -5.27%4.11B | -14.14%1.89B | -27.42%9.1B | -23.91%6.18B | -16.96%4.34B | -12.03%2.2B | 42.35%12.54B |
| Goods services cash paid | 51.52%1.88B | 23.21%6.23B | 11.86%3.76B | 5.44%2.47B | -10.43%1.24B | -21.72%5.06B | -26.09%3.36B | -20.16%2.35B | -2.48%1.39B | 23.02%6.46B |
| Staff behalf paid | 26.11%609.88M | 2.45%1.84B | -5.35%1.25B | -8.35%866.97M | -12.57%483.59M | 1.09%1.79B | 9.99%1.32B | 18.24%945.93M | 18.42%553.12M | 34.04%1.78B |
| All taxes paid | 80.98%181.06M | -44.73%414.81M | -45.91%349.85M | -57.46%229.34M | -65.54%100.04M | 3.67%750.51M | 11.26%646.83M | 68.59%539.17M | 200.53%290.27M | -19.36%723.93M |
| Cash paid relating to other operating activities | 11.98%250.27M | 32.49%583.04M | -16.81%516.93M | -0.77%347.48M | 18.05%223.48M | -26.93%440.06M | 7.96%621.38M | -4.46%350.19M | 66.42%189.31M | 28.82%602.25M |
| Cash outflows from operating activities | 42.65%2.92B | 12.74%9.06B | -1.24%5.88B | -6.31%3.92B | -15.30%2.05B | -15.89%8.04B | -13.82%5.95B | -5.51%4.18B | 15.24%2.42B | 20.41%9.56B |
| Net cash flows from operating activities | -40.90%-230.32M | 19.04%1.27B | 119.30%487.66M | 22.22%193.33M | 26.78%-163.46M | -64.36%1.06B | -81.60%222.37M | -80.26%158.18M | -156.20%-223.25M | 242.26%2.98B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 16.78%891M | -46.09%3.37B | -37.53%3.07B | -58.96%1.46B | -46.07%763M | -22.10%6.25B | -26.21%4.92B | -11.35%3.57B | -13.95%1.41B | 13.11%8.02B |
| Cash received from returns on investments | -78.24%11.08M | -17.43%193.5M | -3.96%139.62M | 42.38%106.18M | 72.10%50.94M | 50.51%234.36M | 5.02%145.38M | -22.80%74.57M | -8.38%29.6M | -15.46%155.71M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -87.32%72.97K | -76.17%25.75M | -98.64%1.41M | -64.16%1.34M | -53.70%575.67K | 70.94%108.04M | 1,433.40%104.06M | -44.46%3.74M | -80.54%1.24M | -66.90%63.2M |
| Cash received relating to other investing activities | ---- | ---- | --1.72M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | 10.76%902.16M | -45.57%3.59B | -37.78%3.22B | -56.90%1.57B | -43.66%814.51M | -20.01%6.59B | -24.13%5.17B | -11.68%3.65B | -14.09%1.45B | 10.36%8.24B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -58.85%107.51M | 19.63%900.89M | 13.71%690.41M | 2.93%436.26M | -8.20%261.23M | -37.21%753.07M | -30.03%607.15M | -17.49%423.83M | -12.91%284.58M | 61.37%1.2B |
| Cash paid to acquire investments | -72.76%235.06M | 29.43%6.03B | -42.01%2.47B | -44.72%1.56B | -35.58%863.07M | -49.25%4.66B | -38.08%4.26B | -21.15%2.82B | -26.99%1.34B | 47.05%9.18B |
| Net cash paid to acquire subsidiaries and other business units | ---- | 421.89%767.59M | 1,405.27%805.15M | -99.74%55.61K | ---- | -91.23%147.08M | -96.67%53.49M | -97.89%21.18M | ---- | --1.68B |
| Cash outflows from investing activities | -69.53%342.57M | 38.49%7.7B | -19.42%3.97B | -38.90%2B | -30.79%1.12B | -53.89%5.56B | -47.38%4.92B | -35.90%3.27B | -24.86%1.62B | 72.58%12.06B |
| Net cash flows from investing activities | 280.63%559.59M | -499.12%-4.11B | -404.42%-750.84M | -211.42%-423.87M | -73.38%-309.8M | 126.98%1.03B | 109.70%246.65M | 139.36%380.42M | 62.70%-178.68M | -897.42%-3.82B |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | --1.3M | --200K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | --1.3M | --200K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | 3.30%467.95M | -18.22%1.76B | 21.33%1.71B | 5.14%1.17B | -33.67%453M | -5.43%2.15B | -23.70%1.41B | 6.00%1.11B | 583.00%683M | --2.28B |
| Cash received relating to other financing activities | --10.15M | 48.80%223.73M | 43.01%180M | 260.00%180M | ---- | --150.36M | --125.86M | --50M | ---- | ---- |
| Cash inflows from financing activities | 5.54%478.1M | -13.84%1.98B | 23.18%1.9B | 16.11%1.35B | -33.67%453M | 1.18%2.3B | -17.52%1.54B | 9.30%1.16B | 583.00%683M | --2.28B |
| Borrowing repayment | 11.29%815.78M | -44.73%1.55B | -17.74%1.72B | 3.44%1.5B | 101.93%733M | 1,769.43%2.8B | 1,839.76%2.09B | 2,541.91%1.45B | --363M | -0.04%149.94M |
| Dividend interest payment | 1,410.03%63.56M | -49.77%412.66M | 25.46%360.29M | -64.69%99.56M | -17.70%4.21M | 104.90%821.62M | -29.93%287.17M | -28.81%281.99M | 1,178.84%5.11M | -47.80%400.99M |
| Cash payments relating to other financing activities | -67.92%64.11M | 7.78%500.31M | 129.99%368.52M | 189.31%308.63M | 284.89%199.85M | -23.68%464.21M | -70.47%160.23M | -74.61%106.68M | -82.05%51.92M | 23.76%608.22M |
| Cash outflows from financing activities | 0.68%943.46M | -39.79%2.46B | -3.55%2.45B | 3.78%1.91B | 123.09%937.06M | 252.75%4.09B | 139.71%2.54B | 111.38%1.84B | 45.01%420.04M | -17.77%1.16B |
| Net cash flows from financing activities | 3.86%-465.36M | 73.25%-477.52M | 44.55%-556.29M | 17.36%-560.9M | -284.08%-484.06M | -259.77%-1.79B | -224.56%-1B | -452.16%-678.72M | 238.64%262.96M | 179.28%1.12B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -238.59%-3.47M | 314.23%3.55M | -4.30%6.33M | 40.99%8.09M | 168.37%2.51M | -153.26%-1.66M | -84.55%6.61M | -79.20%5.74M | -401.78%-3.67M | 66.97%-654.52K |
| Net increase in cash and cash equivalents | 85.38%-139.57M | -1,183.21%-3.32B | -54.14%-813.15M | -482.92%-783.34M | -569.44%-954.81M | 8.61%306.52M | -8.47%-527.55M | -344.63%-134.38M | 47.60%-142.63M | 561.71%282.21M |
| Add:Begin period cash and cash equivalents | -70.99%1.36B | 7.01%4.68B | 7.01%4.68B | 7.01%4.68B | 7.01%4.68B | 6.90%4.37B | 6.90%4.37B | 6.90%4.37B | 6.90%4.37B | -1.47%4.09B |
| End period cash equivalent | -67.29%1.22B | -70.99%1.36B | 0.54%3.86B | -8.08%3.89B | -11.96%3.72B | 7.01%4.68B | 6.69%3.84B | 2.24%4.24B | 10.79%4.23B | 6.90%4.37B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.